JoshuaGelerisMD
Internal Medicine • New York, NYHospital Medicine/Hospitalist
Internal Medicine at New York - Presbyterian Hospital
Dr. Geleris is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
622 W 168th St
New York, NY 10032Phone+1 212-305-2500Fax+1 212-305-3213
Education & Training
New York Presbyterian Hospital (Cornell Campus)Residency, Internal Medicine, 2014 - 2017
Technion-Israel Inst of Technology Faculty of MedicineClass of 2014
Certifications & Licensure
NY State Medical License 2017 - 2026
Publications & Presentations
PubMed
- 1071 citationsObservational Study of Hydroxychloroquine in Hospitalized Patients with Covid-19.Joshua Geleris, Yifei Sun, Jonathan Platt, Jason Zucker, Matthew R. Baldwin
The New England Journal of Medicine. 2020-05-07 - 33 citationsComparison of Trends and In-Hospital Outcomes of Concurrent Carotid Artery Revascularization and Coronary Artery Bypass Graft Surgery: The United States Experience 200...Dmitriy N. Feldman, Rajesh V. Swaminathan, Joshua D. Geleris, Peter M. Okin, Robert M. Minutello
JACC. Cardiovascular Interventions. 2017-02-13 - 20 citationsHospital Readmissions After Implementation of a Discharge Care Program for Patients with COVID-19 Illness.Siqin Ye, Grant Hiura, Elaine Fleck, Aury Garcia, Joshua Geleris
Journal of General Internal Medicine. 2021-01-14
Journal Articles
- Observational Study of Hydroxychloroquine in Hospitalized Patients with Covid-19Joshua Geleris, Neil W Schluger, The New England Journal of Medicine
- Observational Study of Hydroxychloroquine in Hospitalized Patients with Covid-19Joshua Geleris, Neil W Schluger, The New England Journal of Medicine
Authored Content
- Observational Study of Hydroxychloroquine in Hospitalized Patients with Covid-19May 2020
Press Mentions
The Efficacy and Safety of Hydroxychloroquine (HCQ) in Treatment of COVID19 –a Systematic Review and Meta-AnalysisMarch 26th, 2021- All Hands on DeckDecember 23rd, 2020
What Is Hydroxychloroquine? President Trump Calls It a COVID-19 Miracle Drug, but Many Scientists DisagreeMay 21st, 2020- Join now to see all
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
